Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
27,497,586
-
Shares change
-
+1,289,520
-
Total reported value, excl. options
-
$257,653,097
-
Value change
-
+$10,011,387
-
Number of buys
-
52
-
Number of sells
-
-35
-
Price
-
$9.37
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2019
108 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2019.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,497,586 shares
of 37,435,082 outstanding shares and own 73% of the company stock.
Largest 10 shareholders include NWQ INVESTMENT MANAGEMENT COMPANY, LLC (3,421,966 shares), WYNNEFIELD CAPITAL INC (2,795,300 shares), DIMENSIONAL FUND ADVISORS LP (2,405,825 shares), BlackRock Inc. (1,884,319 shares), VANGUARD GROUP INC (1,812,483 shares), Russell Investments Group, Ltd. (1,792,553 shares), FRANKLIN RESOURCES INC (1,516,452 shares), Walthausen & Co., LLC (1,163,450 shares), HEARTLAND ADVISORS INC (1,041,475 shares), and Boston Partners (903,652 shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.